Form 4: Omnicell CEO Randall Lipps Reports Stock Transactions

Omnicell, Inc. CEO Randall Lipps has reported a transaction involving the withholding of shares to cover taxes upon vesting of restricted stock units.

Summary

• Randall A. Lipps, Chairman, President, and CEO of Omnicell, Inc., reported a transaction on May 15, 2026.
• This transaction involved the withholding of 12,347 shares of common stock to cover taxes associated with the vesting of restricted stock units.
• The shares were withheld at a price of $43.12 per share, totaling $523,184.07.
• Following this transaction, Mr. Lipps beneficially owns 523,184 shares of Omnicell common stock.
• Additional holdings include 355,861 shares held in trust with his wife and 8,051 shares held in trust for his children.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine tax settlement for executive compensation rather than a strategic business event or a significant change in ownership.

Positives

• CEO Randall Lipps continues to hold a significant beneficial ownership in Omnicell, Inc., indicating confidence in the company.
• The withholding of shares for tax purposes is a standard procedure upon the vesting of restricted stock units, suggesting normal executive compensation activity.

Negatives

• The transaction represents a disposition of shares, albeit for tax settlement, which could be perceived negatively by some investors if not understood in context.

Risks

• The filing does not explicitly mention any new risks or challenges.
• However, the general risks associated with executive compensation and stock-based awards, such as potential dilution or market fluctuations affecting the value of vested shares, are implicitly present.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. It solely reports a past transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors, reflecting standard compensation practices and ownership changes. This filing by Omnicell's CEO is typical within the healthcare technology sector where stock-based compensation is common.

Stakeholder Impact

• Shareholders: The transaction does not directly impact the number of shares outstanding or the company's financial performance, but it is a standard part of executive compensation. The continued beneficial ownership by the CEO may be viewed positively.
• Employees: This filing is specific to executive compensation and does not directly impact general employees.
• Creditors: No direct impact on creditors is indicated.
• Suppliers/Customers: No direct impact on suppliers or customers is indicated.

Next Steps

• No specific next steps are mentioned in this filing.

Key Dates

Keywords

Omnicell, OMCL, Form 4, Insider Trading, Stock Transaction, Executive Compensation, Restricted Stock Units, Beneficial Ownership, Randall Lipps